BACKGROUND

Resistance to anti-tuberculosis drugs has been increasing.

Resistance is strongly associated to previous TB disease/treatment.

WHO estimates 350 MDR-TB cases annually in Cameroon.

In 2022 the Cameroon reported 172 RR-TB cases less than 350 estimate.

A 2016/2017 survey reported 1.6% RP New PTB Cases.

In 2022, WHO estimated the prevalence to be at 1.4% in Cameroon.

In 2021 Merker et al., reported active transmission of RR-TB.

OBJECTIVES

General Objective

To estimate the prevalence and to describe/evaluate associated risk factors of RR/MDR-TB in newly confirmed PTB cases in Cameroon.

Specific Objectives

• To estimate the prevalence of RR/MDR-TB stratified by age, sex, district and region
• To geolocalize identified patients
• To identify socio-demographic factors associated with RR/MDR-TB
• To identify risk factors associated with RR/MDR-TB
• To characterize the circulating TB strains

Status/Progress Updates

• Protocol has been finalized
• Ethical clearance process engaged
• Several exchange with the NTB program on the implementation plan
• Budget has been finalized
• NTB has confirmed availability of funds
• E-tools for data collection developed

NEXT STEPS

• Finalize training modules
• Workshop with NTB to finalize implementation plan and validate the data collection tools
• Training of project staff
• Data collection process.